ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I - III breast cancer patients. - Braun,S.; Schlimok,G.; Heumos,I.; Schaller,G.; Riethdorf,L.; Riethmuller,G.; Pantel,K. (Cancer Res, 1999)